Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Jones Trading analyst Matthew Erdner initiated coverage on GBank Financial Holdings Inc (NASDAQ: GBFH) with a Buy rating and announced a price target of $55. GBank Financial shares closed at $40.68 on Friday. See how other analysts view this stock.
- Chardan Capital analyst Rudy Li initiated coverage on Reviva Pharmaceuticals Holdings Inc (NASDAQ:
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Jones Trading analyst Matthew Erdner initiated coverage on GBank Financial Holdings Inc (NASDAQ: GBFH) with a Buy rating and announced a price target of $55. GBank Financial shares closed at $40.68 on Friday. See how other analysts view this stock.
- Chardan Capital analyst Rudy Li initiated coverage on Reviva Pharmaceuticals Holdings Inc (NASDAQ:
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Jones Trading analyst Matthew Erdner initiated coverage on GBank Financial Holdings Inc (NASDAQ: GBFH) with a Buy rating and announced a price target of $55. GBank Financial shares closed at $40.68 on Friday. See how other analysts view this stock.
Chardan Capital analyst Rudy Li initiated coverage on Reviva Pharmaceuticals Holdings Inc (NASDAQ: Full story available on Benzinga.com Read MoreANRO, GBFH, GBFH, IMUX, News, Penny Stocks, RVPH, Top Initiations, VSEC, Initiation, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, VSEC, US9182841000, IMUX, RVPH, GBFH, ANRO, News, Penny Stocks, Initiation, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
